ARCHIVES

Bristol Stock Drops Amid New Setbacks, Deepening Firm’s Decline In Oncology

This article is from The Cancer Letter archive.

Vol. 28 No. 14 | April 5, 2002

Download PDF Visit The Full Archive

Related Articles

Advisors Approve New Grant Programs In Breast Pre-Malignancy, Lung Inflammation

November 17, 2006

DeVita Resigns As No. 2 At Sloan-Kettering To “Pursue Clinical Research,” Hospital Says

May 31, 1991

Baltimore Reports On New Method To Aid Leukemia Therapy Design

May 20, 1977

Techniclone Wins Patent For Tumor Necrosis Therapy.

February 25, 2000

NCAB Delays Approval Of New Comprehensive Center Guidelines

October 12, 1979

DCT Board Okay Recompetitions, Delays Decision On Clonogenic Assays

June 24, 1983